Big Human Genome Sciences, Inc. Lupus Drug Nears U.S. Market

March 8, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON, March 7 (Reuters) - Human Genome Sciences Inc's (HGSI.O) lupus drug is poised to win U.S. clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster sales.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory